In this study, hMIKO-1 administration suppressed pulmonary fibrosis and the expression of F4/80, inflammatory cytokines (TNF-α, IL-6, and IL-1β), and fibrotic factors in the lungs of BLM-ILD mice. This evidence concerns the gene IL1B and interstitial lung disease.